Agrm2 antigen

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/47 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 49/00 (2006.01) A61K 51/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C12N 15/12 (2006.01) G01N 33/53 (2006.01) C07K 16/18 (2006.01)

Patent

CA 2651800

The antigen recognized by the antibody produced by a deposited cell line (ATCC accession no. PTA 5411 has been shown to be a fragment of vimentin. This vimentm fragment will be useful in therapy of and screening fo cell proliferative disorders such as cancer.

L'antigène faisant l'objet de cette invention, reconnu par l'anticorps produit par une lignée cellulaire mise en dépôt (ATCC - no. de catalogue PTA 5411) s'est avéré être un fragment de vimentine. Ce fragment de vimentine est utile pour une thérapie et le dépistage de troubles liés à une prolifération cellulaire tels que le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Agrm2 antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agrm2 antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agrm2 antigen will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1463520

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.